International Journal of Drug Policy
Volume 19, Issue 6 , Pages 442-449 , December 2008

Heroin transition risk among daily and non-daily cannabis users who are non-injectors of heroin

  • Avelardo Valdez

      Affiliations

    • Office for Drug and Social Policy Research, Graduate College of Social Work, University of Houston, 237 Social Work Building, Houston, TX 77204-4013, United States
    • Corresponding Author InformationCorresponding author. Fax: +1 713 743 3985.
    • ,
  • Alice Cepeda

      Affiliations

    • Office for Drug and Social Policy Research and Department of Sociology, University of Houston, 237 Social Work Building, Houston, TX 77204-4013, United States
    • Fax: +1 713 743 3985.
    • ,
  • Alan Neaigus

      Affiliations

    • Institute for International Research on Youth at Risk, National Development and Research Institutes, Inc., 71 West 23rd Street, 8th Floor New York, NY 10010, United States
    • ,
  • Amy Russell

      Affiliations

    • Office for Drug and Social Policy Research, Graduate College of Social Work, University of Houston, 237 Social Work Building, Houston, TX 77204-4013, United States
    • Fax: +1 713 743 3985.

Received 20 October 2006 ,Revised 13 June 2007 ,Accepted 18 June 2007.

References 

  1. Amaro H, Whitaker R, Coffman G, Heeren T. Acculturation and marijuana and cocaine use: Findings from HHANES 1982–1984. American Journal of Public Health. 1990;80(Suppl.):54–60
  2. Andrade X, Sifaneck SJ, Neaigus A. Dope sniffers in New York City: An ethnography of heroin markets and patterns of use. Journal of Drug Issues. 1999;29(2):271–298
  3. Bailey KB. Typologies and taxonomies: An introduction to classification techniques. In:  Lewis-Beck MS editors. Quantitative applications in the social sciences. Thousand Oaks, CA: Sage Publications; 1994;p. 7–102
  4. Budney AJ, Bickel WK, Amass L. Marijuana use and treatment outcome among opioid-dependent patients. Addiction. 1998;93(4):493–503
  5. Carlson RG, Wang J, Siegal HA, Falck RS, Guo J. An ethnographic approach to targeted sampling: Problems and solutions in AIDS prevention research among injection drug and crack-cocaine users. Journal of the Society for Applied Anthropology. 1994;53(2):279–286
  6. Casriel C, Des Jarlais DC, Rodriguez R, Friedman SR, Stepherson B, Khuri E. Working with heroin sniffers: Clinical issues in preventing drug injection. Journal of Substance Abuse Treatment. 1990;7:1–10
  7. Casriel C, Rockwell R, Stepherson B. Heroin sniffers: Between two worlds. Journal of Psychoactive Drugs. 1988;20(4):437–440
  8. Chitwood DD, Comerford M, Sanchez J. Prevalence and risk factors for HIV among sniffers, short-term injectors, and long-term injectors of heroin. Journal of Psychoactive Drugs. 2003;35(4):445–453
  9. Chitwood DD, Sanchez J, Comerford M, Page JB, McBride DC, Kitner KR. First injection and current risk factors for HIV among new and long-term injection drug users. AIDS Care. 2000;12(3):313–320
  10. Clatts M, Davis W, Atillasoy A. Hitting a moving target: The use of ethnographic methods in the development of sampling strategies for the evaluation of AIDS outreach programs for homeless youth in New York City. NIDA Research Monograph. 1995;157:117–135
  11. Darke S, Kaye S, Ross J. Transitions between the injection of heroin and amphetamines. Addiction. 1999;94(12):1795–1803
  12. Des Jarlais DC, Casriel C, Friedman SR, Rosenblum A. AIDS and the transition to illicit drug injection—results of a randomized trial prevention program. British Journal of Addiction. 1992;87(3):493–498
  13. Epstein DH, Preston KL. Does cannabis use predict poor outcome for heroin-dependent patients on maintenance treatment? Past findings and more evidence against. Addiction. 2003;98:269–279
  14. Gossop M, Griffiths P, Powis B, Strang J. Severity of dependence and route of administration of heroin, cocaine and amphetamines. British Journal of Addiction. 1992;87:1527–1536
  15. Gyarmathy VA, Neaigus A, Miller M, Friedman SR, Des Jarlais DC. Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users. Journal of Acquired Immune Deficiency Syndromes. 2002;30:448–456
  16. Hall W, Hando J. Route of administration and adverse effects of amphetamine use among young adults in Sydney, Australia. Drug and Alcohol Review. 1994;13:277–284
  17. Heckathorn DD. Respondent-driven sampling: A new approach to the study of hidden populations. Social Problems. 1997;44(2):174–199
  18. In:  Kandel DB editors. Stages and pathways of drug involvement: Examining the gateway hypothesis. New York: Cambridge University Press; 2002;
  19. Kandel DB, Yamaguchi K. Stages if drug involvement in the U.S. population. In:  Kandel DB editors. Stages and pathways of drug involvement: Examining the gateway hypothesis. Cambridge, UK: Cambridge University Press; 2002;p. 65–89
  20. Kaufman JM, Chitwood DD, Comerford M, Koo D. Characteristics and patterns of use among regular heroin sniffers. Journal of Drug Issues. 2004;22:805–830
  21. Kelley MS, Chitwood DD. Effects of drug treatment for heroin sniffers: A protective factor against moving to injection?. Social Science and Medicine. 2004;58:2083–2092
  22. McElrath K, Chitwood DD, Griffin DK, Comerford M. The consistency of self-reported HIV risk behavior among injection drug users. American Journal of Public Health. 1994;84:1965–1970
  23. McQueen A, Getz JG, Bray JH. Acculturation, substance use, and deviant behavior: Examining separation and family conflict as mediators. Child Development. 2003;74(6):1737–1750
  24. Neaigus A, Atillasoy A, Friedman SR, Andrade X, Miller M, Idelfonso G, et al. Trends in the noninjected use of heroin and factors associated with the transition to injecting. In:  Inciardi JA,  Harrison LD editor. Heroin in the age of crack-cocaine. Vol. 6:Thousand Oaks, CA: Sage; 1998;p. 131–159
  25. Neaigus A, Gyarmathy A, Miller M, Frajzyngier VM, Friedman SR, Don CDJ. Transitions to injecting drug use among noninjecting heroin users. JAIDS: Journal of Acquired Immune Deficiency Syndromes. 2006;41(4):493–503
  26. Neaigus A, Miller M, Friedman SR, Hagen DL, Sifaneck SJ, Idelfonso G, et al. Potential risk factors for the transition to injecting among non-injecting heroin users: A comparison of former injectors and never injectors. Addiction. 2001;96:847–860
  27. Nirenberg TD, Liepman MR, Celluci T, Swift RM, Sirota AD. Cannabis versus other illicit drug use among methadone maintenance patients. Psychology of Addictive Behaviors. 1996;10(4):222–227
  28. Sanchez J, Comerford M, Chitwood DD, Fernandez MI, McCoy CB. High risk sexual behaviors among heroin sniffers who have no history of injection drug use: Implications for HIV risk reduction. AIDS Care. 2002;14(3):391–398
  29. Saxon AJ, Calsyn DA, Greenberg D, Blaes P, Haver VM, Stanton V. Urine screening for marijuana among methadone-maintained patients. American Journal of Addictions. 1993;2:207–211
  30. Seivewright N. Methadone treatment outcomes appear mainly unaffected by cannabis abuse. Addiction. 2003;98:251–252
  31. Sifaneck SJ, Kaplan CD. Keeping off, stepping on and stepping off: The steppingstone theory reevaluated in the context of the Dutch cannabis experience. Contemporary Drug Problems. 1995;22(3):486–512
  32. Sotheran JL, Goldsmith DS, Blasco M, Friedman SR. Heroin sniffing as self-regulation among injecting and non-injecting heroin users. Journal of Drug Issues. 1999;29(2):401–422
  33. Strang J, Griffiths P, Powis B, Abbey J, Gossop M. How constant is an individual's route of heroin administration?. Data from Treatment and Non-Treatment Samples Drug and Alcohol Dependence. 1997;46:115–118
  34. Ten Houten WD. Generalization and statistical inference from snowball samples. Bulletin de Methodologie Sociologique. 1992;37:25–40
  35. Valdez A. Mexican American youth and adult prison gangs in a changing heroin market. Journal of Drug Issues. 2005;35(4):843–867
  36. van Ameijden EJC, van den Hoek JA, Hartgers C, Coutinho RA. Risk factors for the transition from noninjection to injection drug use and accompanying AIDS risk behavior in a cohort of drug users. American Journal of Epidemiology. 1994;139(12):1153–1163
  37. van Vliet HJ. Separation of drug markets and the normalization of drug problems in the Netherlands: An example for other nations. Journal of Drug Issues. 1990;20(3):463–471
  38. Vega WA, Alderete E, Kolody B, Aguilar-Gaxiola S. Illicit drug use among Mexicans and Mexican Americans in California: The effects of gender and acculturation. Addiction. 1998;93(12):1839–1850
  39. Watters JK, Biernacki P. Targeted sampling: Options for the study of hidden populations. Social Problems. 1989;36(4):416–430
  40. Yin Z, Valdez A, Mata AG, Kaplan C. Developing a filed-intensive methodology for generating a randomized sample for gang research. Free Inquiry Special Issue: Gangs, Drugs, and Violence. 1996;24(2):195–204

PII: S0955-3959(07)00114-4

doi: 10.1016/j.drugpo.2007.06.004

International Journal of Drug Policy
Volume 19, Issue 6 , Pages 442-449 , December 2008

Article Tools